Protective effects of Mosla Chinensis Maxim against Lung Injury
release_idfjce7wwvdtvdk57ngu7qj2my
by
Hui-Chun Ku,
Shih-Yi Lee,
Yung-Kai Lin,
Yung-Hsiang Lin,
Chi-Fu Chiang
2023 Volume 11, Issue 11, p389-396
Abstract
Lung fibrosis is a common form of interstitial lung disease. Traditional Chinese medicinal plants have the ability to suppress lung inflammation, but there are relatively few studies on the relationship between Mosla Chinensis Maxim and lung injury. The purpose of this study was to investigate whether Mosla Chinensis Maxim extract (MCME) can alleviate lung injury. This study utilized lung epithelial cells, A549, treated MCME (0.25mg/mL), and analyzed the wound-healing ability, inflammatory cytokines, and cell-cell adheren junctions (E-cadherin). Bleomycin was used to induced lung fibrosis in an animal model, which were then treated with MCME. The results showed that MCME improved cellular repair capacity by 30% compared to the mock group, inhibited IL-8 by approximately 60%, and increased the E-cadherin expression compared to the lipopolysaccharide group. In an animal model, administration of MCME (50 mg/kg) for 14 days alleviated the bleomycin-induced pathological changes in the lungs and fibrosis. This study demonstrated that MCME improved lung injury.
In application/xml+jats
format
Archived Files and Locations
application/pdf
475.0 kB
file_sg7ywrm6sjeq3awifbcjeef64m
|
saspublishers.com (publisher) web.archive.org (webarchive) |
article-journal
Stage
published
Date 2023-11-24
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar